Clinical Trials · NCT05136287
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Jose Seijas Amigo
- Enrollment
- 140
- Start date
- Feb 2022
- Locations
- 11 sites, Spain
- Primary endpoint
- Weight loss